Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report
Year: 2000
Type: article
Source: Leukemia
Authors: E Vilmer, S Suciu, A Ferster, Y Bertrand, H Cavé, A Thyss, Y Benoit, N Dastugue, M Fournier, G Souillet, A-M Manel, A Robert, B Nelken, F Millot, P Lutz, X Rialland, F Mechinaud, P Boutard, C Behar, J-M Chantraine, E Plouvier, G Laureys, P Brock, A Uyttebroeck, G Margueritte, D Plantaz, L Norton, N Francotte, J Gyselinck, C Waterkeyn, G Solbu, N Philippe, J Otten
Institutions: Hôpital Robert-Debré, European Organisation for Research and Treatment of Cancer, European Organisation for Research and Treatment of Cancer, Hospices Civils de Lyon, Hôpital Debrousse, Centre Antoine Lacassagne, Ghent University Hospital, Hôpital Purpan, Centre Hospitalier Universitaire de Lille, Hôpital d'Hautepierre, Centre Hospitalier Universitaire d'Angers, Centre Hospitalier Universitaire de Caen Normandie, Centre hospitalier régional de la Citadelle, Hôpital Saint-Jacques, Universitair Ziekenhuis Leuven, Hôpital Arnaud de Villeneuve, Hospital de São João, Clinic of Hope, Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: childhood acute lymphoblastic leukemia, long-term outcomes, event-free survival, central nervous system relapse, radiotherapy omission, cytarabine, methotrexate, 6-mercaptopurine, L-asparaginase, prognostic factors, minimal residual disease, corticosteroid response, genetic abnormalities, maintenance therapy
Open Access status: closed
Funder: National Cancer Institute
OpenAlex ID: W11202050
